I just noticed that PepGen has been upgraded to a 'Buy' with analysts targeting a price of $17. Since the stock recently rebounded nearly 20%, I belie...
Read
More
I just noticed that PepGen has been upgraded to a 'Buy' with analysts targeting a price of $17. Since the stock recently rebounded nearly 20%, I believe it can continue to gain momentum, especially if they lift the FDA hold on their clinical trials.